GSK reaches up to $2.2 billion settlement in Zantac US state court …
WEB10 hours ago · GSK said on Wednesday it had reached agreements with ten plaintiff firms, representing 93% of U.S. state court Zantac product liability cases pending against the drugmaker, for up to $2.2 billion.
GSK to Settle 80,000 Zantac Cases for Up to $2.2 Billion
WEB10 hours ago · GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to contamination of its Zantac reflux medication with a suspected carcinogen.
GSK shares tumble after Delaware court ruling on Zantac - Financial Times
WEBJun 3, 2024 · GSK and the other drugmakers that sold Zantac dispute these claims. The London-listed group said it planned to appeal against the Delaware ruling. Shares in GSK were down 9.5 per cent on Monday ...
GSK reaches $2.2bn heartburn medication Zantac settlement in US
WEB9 hours ago · GSK has reached a $2.2bn settlement to resolve the vast majority of cases linked to its heartburn medicine Zantac, in a move that will help assuage legal concerns overhanging the UK drugmaker. The ...
GSK asks to appeal Delaware ruling allowing Zantac cases to go …
WEBJun 10, 2024 · GSK and other drugmakers on Monday asked a Delaware court for permission to appeal a ruling allowing more than 70,000 lawsuits claiming that heartburn drug Zantac causes cancer to go forward.
GSK to Settle 80,000 Zantac Cases for Up to $2.2 Billion
WEB10 hours ago · Bloomberg News. GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to contamination of its Zantac reflux medication with a suspected carcinogen. The cases represent about 93% of those against the company involving Zantac, GSK said Wednesday in a statement.
After Delaware decision, GSK faces $2B to settle Zantac lawsuits
WEBJun 3, 2024 · There was little share-price impact for Pfizer, which held rights to Zantac from 1998 to 2006, or for Sanofi, which sold the heartburn drug from 2016 to 2019.Boehringer, a Germany-based which is ...
Delaware top court will hear drugmakers' appeal to end Zantac …
WEBAug 27, 2024 · Delaware's highest court said on Tuesday it will hear an appeal by GSK and other drugmakers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer.
Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by …
WEBJul 1, 2024 · First approved in 1983, Zantac became the world's best-selling medicine in 1988 and one of the first to top $1 billion in annual sales. It was originally marketed by a forerunner of GSK and later ...
Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts
WEBApr 5, 2024 · Zantac heartburn pills are seen in this picture illustration taken October 1, 2019. Sanofi has reached an agreement in principle to settle 4,000 US lawsuits linking the discontinued heartburn drug ...